U.S. Biothrax Market Analysis 2034: Increasing Focus on Anthrax Prevention and Biodefense Preparedness
The US represents a key market for BioThrax, supported by federal investments in biological defense and public health security. Demand is influenced by military immunization programs and government efforts to maintain adequate anthrax vaccine supplies. Continued emphasis on preparedness for biological threats reinforces the importance of BioThrax in the country's medical countermeasure...
0 Comments 0 Shares 26 Views 0 Reviews